$PPHM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Avid Bioservices, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Avid Bioservices, Inc.. Get notifications about new insider transactions in Avid Bioservices, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 08 2014 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 1.75 | 250,000 | 437,500 | 1,602,000 | |
| May 08 2014 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 1.75 | 250,000 | 437,500 | 1,532,000 | |
| May 08 2014 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | V.P., Clinical and ... | Option Exercise | A | 1.75 | 100,000 | 175,000 | 785,000 | |
| May 08 2014 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 1.75 | 200,000 | 350,000 | 1,147,500 | |
| May 08 2014 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 1.75 | 400,000 | 700,000 | 2,176,137 | |
| May 08 2014 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 1.75 | 250,000 | 437,500 | 1,532,000 | |
| May 08 2014 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Option Exercise | A | 1.75 | 100,000 | 175,000 | 690,500 | |
| May 01 2014 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 1.11 | 6,571 | 7,294 | 78,803 | 72.2 K to 78.8 K (+9.10 %) |
| May 01 2014 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | J | 0.95 | 87,363 | 82,995 | 1,776,137 | |
| May 01 2014 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 1.11 | 4,020 | 4,462 | 169,892 | 165.9 K to 169.9 K (+2.42 %) |
| May 01 2014 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Sell | J | 0.00 | 25,662 | 0 | 165,872 | 191.5 K to 165.9 K (-13.40 %) |
| Nov 01 2013 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 1.08 | 4,131 | 4,461 | 191,534 | 187.4 K to 191.5 K (+2.20 %) |
| Nov 01 2013 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 1.08 | 6,752 | 7,292 | 72,232 | 65.5 K to 72.2 K (+10.31 %) |
| Oct 17 2013 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 1.39 | 250,000 | 347,500 | 1,933,500 | |
| Oct 17 2013 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | D | 0.46 | 250,000 | 115,000 | 1,683,500 | |
| Oct 17 2013 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Grant | A | 0.00 | 100,000 | 0 | 187,403 | 87.4 K to 187.4 K (+114.41 %) |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | Ziebell Mark R | V.P., General Couns ... | Option Exercise | A | 1.41 | 175,000 | 246,750 | 560,000 | |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 1.41 | 250,000 | 352,500 | 1,402,000 | |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Option Exercise | A | 1.41 | 100,000 | 141,000 | 709,000 | |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 1.41 | 250,000 | 352,500 | 1,352,000 | |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | Masten Jeffrey L. | V.P. Quality | Option Exercise | A | 1.41 | 100,000 | 141,000 | 614,103 | |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 1.41 | 200,000 | 282,000 | 1,007,500 | |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 1.41 | 400,000 | 564,000 | 1,933,500 | |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 1.41 | 250,000 | 352,500 | 1,352,000 | |
| May 08 2013 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Option Exercise | A | 1.41 | 100,000 | 141,000 | 590,500 | |
| May 01 2013 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 0.71 | 6,516 | 4,626 | 87,403 | 80.9 K to 87.4 K (+8.06 %) |
| May 01 2013 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 0.71 | 11,988 | 8,511 | 101,491 | 89.5 K to 101.5 K (+13.39 %) |
| May 01 2013 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 0.71 | 10,481 | 7,442 | 65,480 | 55 K to 65.5 K (+19.06 %) |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | Ziebell Mark R | V.P., General Couns ... | Option Exercise | A | 1.18 | 150,000 | 177,000 | 385,000 | |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 1.18 | 250,000 | 295,000 | 1,152,000 | |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Option Exercise | A | 1.18 | 150,000 | 177,000 | 609,000 | |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 1.18 | 250,000 | 295,000 | 1,102,000 | |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | Masten Jeffrey L. | V.P. Quality | Option Exercise | A | 1.18 | 150,000 | 177,000 | 514,103 | |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 1.18 | 200,000 | 236,000 | 807,500 | |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 1.18 | 200,000 | 236,000 | 1,573,500 | |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 1.18 | 250,000 | 295,000 | 1,102,000 | |
| Dec 28 2012 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Option Exercise | A | 1.18 | 150,000 | 177,000 | 490,500 | |
| Nov 01 2012 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 0.39 | 11,000 | 4,290 | 80,887 | 69.9 K to 80.9 K (+15.74 %) |
| Nov 01 2012 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 0.39 | 20,885 | 8,145 | 89,503 | 68.6 K to 89.5 K (+30.44 %) |
| Nov 01 2012 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 0.39 | 17,980 | 7,012 | 54,999 | 37 K to 55 K (+48.57 %) |
| May 08 2012 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 0.46 | 250,000 | 115,000 | 852,000 | |
| May 08 2012 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 0.46 | 250,000 | 115,000 | 922,000 | |
| May 08 2012 | PPHM | PEREGRINE PHARMACE ... | Masten Jeffrey L. | V.P. Quality | Option Exercise | A | 0.46 | 150,000 | 69,000 | 364,103 | |
| May 08 2012 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Option Exercise | A | 0.46 | 150,000 | 69,000 | 459,000 | |
| May 08 2012 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 0.46 | 250,000 | 115,000 | 852,000 | |
| May 08 2012 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Option Exercise | A | 0.46 | 125,000 | 57,500 | 340,500 | |
| May 08 2012 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 0.46 | 200,000 | 92,000 | 607,500 | |
| May 08 2012 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 0.46 | 500,000 | 230,000 | 1,373,500 | |
| May 01 2012 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 0.40 | 12,498 | 4,999 | 68,618 | 56.1 K to 68.6 K (+22.27 %) |
| May 01 2012 | PPHM | PEREGRINE PHARMACE ... | Masten Jeffrey L. | V.P. Quality | Buy | J | 0.40 | 12,498 | 4,999 | 12,498 | 0 to 12.5 K |
| May 01 2012 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 0.40 | 12,498 | 4,999 | 37,019 | 24.5 K to 37 K (+50.97 %) |
| May 01 2012 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 0.40 | 10,726 | 4,290 | 69,887 | 59.2 K to 69.9 K (+18.13 %) |
| Mar 15 2012 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 0.62 | 16,000 | 9,934 | 126,000 | 110 K to 126 K (+14.55 %) |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | V.P., Clinical & Re ... | Option Exercise | A | 0.95 | 140,000 | 133,000 | 309,000 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | Masten Jeffrey L. | V.P. Quality | Option Exercise | A | 0.95 | 36,250 | 34,438 | 214,103 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | Masten Jeffrey L. | V.P. Quality | Option Exercise | A | 0.95 | 21,750 | 20,663 | 177,853 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 0.95 | 140,000 | 133,000 | 407,500 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Option Exercise | A | 0.95 | 58,000 | 55,100 | 215,500 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 0.95 | 267,439 | 254,067 | 873,500 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 0.95 | 82,561 | 78,433 | 606,061 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 0.95 | 90,000 | 85,500 | 602,000 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 0.95 | 90,000 | 85,500 | 602,000 | |
| Feb 21 2012 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 0.95 | 90,000 | 85,500 | 672,000 | |
| Nov 02 2011 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 0.89 | 5,122 | 4,559 | 56,120 | 51 K to 56.1 K (+10.04 %) |
| Nov 02 2011 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 0.89 | 5,122 | 4,559 | 24,521 | 19.4 K to 24.5 K (+26.40 %) |
| Nov 02 2011 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 0.89 | 4,804 | 4,276 | 59,161 | 54.4 K to 59.2 K (+8.84 %) |
| Jul 05 2011 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical and Re ... | Sell | D | 0.00 | 5,000 | 0 | 5,436 | 10.4 K to 5.4 K (-47.91 %) |
| Jul 05 2011 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Sell | D | 0.00 | 9,000 | 0 | 41,998 | 51 K to 42 K (-17.65 %) |
| Jul 05 2011 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Sell | D | 0.00 | 14,000 | 0 | 40,357 | 54.4 K to 40.4 K (-25.76 %) |
| Jul 05 2011 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Sell | D | 0.00 | 5,000 | 0 | 14,399 | 19.4 K to 14.4 K (-25.77 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 2.44 | 142,000 | 346,480 | 582,000 | |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | V.P. Clinical & Reg ... | Option Exercise | A | 2.44 | 30,000 | 73,200 | 174,645 | |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | V.P. Clinical & Reg ... | Sell | D | 0.00 | 5,000 | 0 | 15,436 | 20.4 K to 15.4 K (-24.47 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | V.P. Clinical & Reg ... | Sell | D | 0.00 | 5,000 | 0 | 20,436 | 25.4 K to 20.4 K (-19.66 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 2.44 | 142,000 | 346,480 | 512,000 | |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 2.44 | 57,500 | 140,300 | 294,500 | |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Sell | D | 0.00 | 9,000 | 0 | 59,998 | 69 K to 60 K (-13.04 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Sell | D | 0.00 | 9,000 | 0 | 68,998 | 78 K to 69 K (-11.54 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | J | 1.28 | 5,947 | 7,612 | 77,998 | 72.1 K to 78 K (+8.25 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 2.44 | 142,500 | 347,700 | 553,500 | |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Sell | D | 0.00 | 14,000 | 0 | 68,357 | 82.4 K to 68.4 K (-17.00 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Sell | D | 0.00 | 14,000 | 0 | 82,357 | 96.4 K to 82.4 K (-14.53 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | J | 1.28 | 3,046 | 3,899 | 96,357 | 93.3 K to 96.4 K (+3.26 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 2.44 | 142,000 | 346,480 | 512,000 | |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Option Exercise | A | 2.44 | 30,000 | 73,200 | 157,500 | |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Sell | D | 0.00 | 5,000 | 0 | 24,399 | 29.4 K to 24.4 K (-17.01 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Sell | D | 0.00 | 5,000 | 0 | 29,399 | 34.4 K to 29.4 K (-14.54 %) |
| May 03 2011 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Buy | J | 1.28 | 5,371 | 6,875 | 34,399 | 29 K to 34.4 K (+18.50 %) |
| Feb 11 2011 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP, Clinical/Regula ... | Grant | A | 0.00 | 5,000 | 0 | 25,436 | 20.4 K to 25.4 K (+24.47 %) |
| Feb 11 2011 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 72,051 | 63.1 K to 72.1 K (+14.27 %) |
| Feb 11 2011 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Grant | A | 0.00 | 14,000 | 0 | 93,311 | 79.3 K to 93.3 K (+17.65 %) |
| Feb 11 2011 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Grant | A | 0.00 | 5,000 | 0 | 29,028 | 24 K to 29 K (+20.81 %) |
| Jan 04 2011 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP Clinical/Regulat ... | Sell | D | 0.00 | 5,000 | 0 | 20,436 | 25.4 K to 20.4 K (-19.66 %) |
| Jan 04 2011 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Sell | D | 0.00 | 14,000 | 0 | 79,311 | 93.3 K to 79.3 K (-15.00 %) |
| Jan 04 2011 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Sell | D | 0.00 | 9,000 | 0 | 63,051 | 72.1 K to 63.1 K (-12.49 %) |
| Jan 04 2011 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | V.P., Intellectual ... | Sell | D | 0.00 | 5,000 | 0 | 24,028 | 29 K to 24 K (-17.22 %) |
| Nov 09 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 1.60 | 8,400 | 13,440 | 110,000 | 101.6 K to 110 K (+8.27 %) |
| Nov 09 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 1.58 | 1,600 | 2,528 | 101,600 | 100 K to 101.6 K (+1.60 %) |
| Sep 27 2010 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | P | 1.34 | 6,684 | 8,957 | 72,051 | 65.4 K to 72.1 K (+10.23 %) |
| Sep 24 2010 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Buy | P | 1.33 | 5,000 | 6,650 | 65,367 | 60.4 K to 65.4 K (+8.28 %) |
| Sep 24 2010 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Buy | P | 1.33 | 5,000 | 6,650 | 93,311 | 88.3 K to 93.3 K (+5.66 %) |
| Feb 19 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.31 | 3,100 | 10,261 | 100,000 | 96.9 K to 100 K (+3.20 %) |
| Feb 19 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.26 | 1,200 | 3,912 | 96,900 | 95.7 K to 96.9 K (+1.25 %) |
| Feb 18 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.27 | 3,200 | 10,464 | 95,700 | 92.5 K to 95.7 K (+3.46 %) |
| Feb 18 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.26 | 9,000 | 29,340 | 92,500 | 83.5 K to 92.5 K (+10.78 %) |
| Feb 18 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.25 | 3,500 | 11,375 | 83,500 | 80 K to 83.5 K (+4.38 %) |
| Feb 18 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.24 | 2,000 | 6,480 | 80,000 | 78 K to 80 K (+2.56 %) |
| Feb 08 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.07 | 3,756 | 11,531 | 78,000 | 74.2 K to 78 K (+5.06 %) |
| Feb 08 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.06 | 244 | 747 | 74,244 | 74 K to 74.2 K (+0.33 %) |
| Feb 08 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.05 | 9,100 | 27,755 | 74,000 | 64.9 K to 74 K (+14.02 %) |
| Feb 08 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.03 | 4,900 | 14,847 | 64,900 | 60 K to 64.9 K (+8.17 %) |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 2.93 | 250,000 | 732,500 | 440,000 | |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 2.93 | 250,000 | 732,500 | 460,000 | |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 2.93 | 250,000 | 732,500 | 370,000 | |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 2.93 | 221,000 | 647,530 | 411,000 | |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Grant | A | 0.00 | 70,000 | 0 | 88,311 | 18.3 K to 88.3 K (+382.28 %) |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 2.93 | 120,000 | 351,600 | 237,000 | |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 60,367 | 15.4 K to 60.4 K (+292.84 %) |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP Clinical/Regulat ... | Option Exercise | A | 2.93 | 75,000 | 219,750 | 154,645 | |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | Shan Joseph | VP Clinical/Regulat ... | Grant | A | 0.00 | 25,000 | 0 | 25,436 | 436 to 25.4 K (+5,733.94 %) |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | VP, Intellectual Pr ... | Option Exercise | A | 2.93 | 75,000 | 219,750 | 127,500 | |
| Feb 03 2010 | PPHM | PEREGRINE PHARMACE ... | Fussey Shelley PM | VP, Intellectual Pr ... | Grant | A | 0.00 | 25,000 | 0 | 29,028 | 4 K to 29 K (+620.66 %) |
| Jan 19 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.21 | 10,000 | 32,100 | 60,000 | 50 K to 60 K (+20.00 %) |
| Jan 19 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.20 | 10,000 | 32,000 | 50,000 | 40 K to 50 K (+25.00 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.16 | 4,500 | 14,220 | 40,000 | 35.5 K to 40 K (+12.68 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.16 | 667 | 2,108 | 35,500 | 34.8 K to 35.5 K (+1.91 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.15 | 1,000 | 3,150 | 34,833 | 33.8 K to 34.8 K (+2.96 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.14 | 1,000 | 3,140 | 33,833 | 32.8 K to 33.8 K (+3.05 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.14 | 2,000 | 6,280 | 32,833 | 30.8 K to 32.8 K (+6.49 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.11 | 2,000 | 6,220 | 30,833 | 28.8 K to 30.8 K (+6.94 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.10 | 5,500 | 17,050 | 28,833 | 23.3 K to 28.8 K (+23.57 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.09 | 930 | 2,874 | 23,333 | 22.4 K to 23.3 K (+4.15 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.08 | 403 | 1,241 | 22,403 | 22 K to 22.4 K (+1.83 %) |
| Jan 12 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.05 | 2,000 | 6,100 | 22,000 | 20 K to 22 K (+10.00 %) |
| Jan 11 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.02 | 964 | 2,911 | 20,000 | 19 K to 20 K (+5.06 %) |
| Jan 11 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 3.02 | 1,560 | 4,711 | 19,036 | 17.5 K to 19 K (+8.93 %) |
| Jan 11 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 2.98 | 8,600 | 25,628 | 17,476 | 8.9 K to 17.5 K (+96.89 %) |
| Jan 11 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 2.96 | 2,000 | 5,920 | 8,876 | 6.9 K to 8.9 K (+29.09 %) |
| Jan 11 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 2.95 | 1,160 | 3,422 | 6,876 | 5.7 K to 6.9 K (+20.29 %) |
| Jan 11 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 2.95 | 1,340 | 3,953 | 5,716 | 4.4 K to 5.7 K (+30.62 %) |
| Jan 11 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 2.77 | 4,000 | 11,080 | 4,376 | 376 to 4.4 K (+1,063.83 %) |
| Jan 11 2010 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 2.77 | 376 | 1,042 | 376 | 0 to 376 |
| Jan 15 2008 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Buy | P | 0.39 | 35,000 | 13,650 | 2,192,199 | 2.2 M to 2.2 M (+1.62 %) |
| Jan 11 2008 | PPHM | PEREGRINE PHARMACE ... | Waltz Thomas A | Director | Option Exercise | A | 0.39 | 250,000 | 97,500 | 600,000 | |
| Jan 11 2008 | PPHM | PEREGRINE PHARMACE ... | JOHNSON CARLTON M | Director | Option Exercise | A | 0.39 | 250,000 | 97,500 | 1,300,000 | |
| Jan 11 2008 | PPHM | PEREGRINE PHARMACE ... | SWARTZ ERIC S | Director | Option Exercise | A | 0.39 | 250,000 | 97,500 | 950,000 | |
| Jan 11 2008 | PPHM | PEREGRINE PHARMACE ... | POHL DAVID | Director | Option Exercise | A | 0.39 | 250,000 | 97,500 | 600,000 | |
| Jan 11 2008 | PPHM | PEREGRINE PHARMACE ... | LYTLE PAUL J | Chief Financial Off ... | Option Exercise | A | 0.39 | 150,000 | 58,500 | 870,833 | |
| Jan 11 2008 | PPHM | PEREGRINE PHARMACE ... | King F David | V.P., Business Deve ... | Option Exercise | A | 0.39 | 100,000 | 39,000 | 300,000 | |
| Jan 11 2008 | PPHM | PEREGRINE PHARMACE ... | KING STEVEN W | President & CEO | Option Exercise | A | 0.39 | 250,000 | 97,500 | 1,360,833 |